Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

See if Borderline Personality Disorder can be viewed as a Relationship-Use Disorder

Official title: Conceptualizing Borderline Personality Disorder as a Relationship Use Disorder

Run by University Hospital, Montpellier · NCT07337889 · Data updated 2026-11-12

Researchers are testing whether BPD symptoms reflect an addiction-like reliance on interpersonal relationships, compared with bipolar disorder and healthy controls.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment194 (estimated)
SponsorUniversity Hospital, Montpellier
Academic / other
Locations1 site (Montpellier)
StatusRecruiting
StartedJune 1, 2026
Main results expectedApril 1, 2028
Study endsAugust 1, 2028
Registry record updatedJune 22, 2026
Trial IDNCT07337889 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18-45 with BPD confirmed by SCID (without bipolar disorder), or adults with bipolar disorder without BPD, or healthy controls without psychiatric disorders.

Probably not a fit

Individuals with psychotic disorders, those unable to consent, or those not affiliated with social security may not benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study examines a novel way to conceptualize borderline personality disorder as a relationship-use disorder, focusing on addictive-like patterns in seeking external validation. Participants will complete a relationship-use questionnaire to explore how perceived self-worth and emotional dysregulation relate to relationship behaviors. The study includes adults with BPD without bipolar disorder, adults with bipolar disorder without BPD, and healthy controls, using SCID-confirmed diagnoses. It is conducted at CHU Montpellier under the University Hospital of Montpellier with no stated collaborator sites. The aim is to see if relationship dynamics meet DSM-5 addiction criteria and how these dynamics interact with self-perception and regulation.

Why it matters

Potential benefit: If successful, the study could improve understanding of BPD and inform novel approaches to treatment by addressing relationship-use patterns.

How similar studies have gone: Previous work has explored addiction-like features in social and interpersonal behaviors, but this specific relationship-use framing for BPD is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* General : aged 18-45
* Specific :
* Borderline personality disorder (BPD)assessed by SCID, without bipolar disorder
* Bipolar disorder (assessed by SCID), without BPD (evaluated by SCID)
* Healthy controls with no psychiatric disorders (screened by SCID).

Exclusion Criteria:

* Psychotic disorders (evaluated by SCID)
* lack of informed consent
* Not affiliated with social security
* Under judicial or administrative confinement or involuntary hospitalization
* Protected by law (e.g., under guardianship)
* Pregnancy or breastfeeding
* Inability to understand, speak, or write in French
* Inability to understand the study's purpose or methodology
* Excluded from another study during the exclusion period
* Participants who have received over €6000 in annual indemnities
* For Bipolar Participants (without BPD) : Current moderate or severe depressive episode (BDI score \> 18) or Current hypomanic/manic episode (YMRS \< 12)

Where it's running

  • CHU Montpellier
    Montpellier, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.